Skip to main content

Find Drugs & Conditions

Drugs.com is the most popular, comprehensive and up-to-date source of drug information online. Providing free, peer-reviewed, accurate and independent data on more than 24,000 prescription drugs, over-the-counter medicines & natural products.

FDA Approves Winrevair (sotatercept-csrk) a First-in-Class Treatment for Adults with Pulmonary Arterial Hypertension

(BUSINESS WIRE) March 26, 2024 -- Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that the U.S. Food and...

FDA Approves Medexus's Supplemental Biologics License Application for Ixinity to Treat Hemophilia B in Pediatric Patients

March 26, 2024 - Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) today announced that the US Food and Drug Administration (FDA) recently approved Medexus's...

Ultomiris Approved in the US for the Treatment of Adults with Neuromyelitis Optica Spectrum Disorder (NMOSD)

Ultomiris (ravulizumab-cwvz) has been approved in the United States (US) as the first and only long-acting C5 complement inhibitor for the treatment of...

FDA Approves Duvyzat (givinostat) for Duchenne Muscular Dystrophy

(BUSINESS WIRE)-- Mar 22, 2024 -- Italfarmaco S.p.A. announced today that the U.S. Food and Drug Administration (FDA) has approved Duvyzat™ (givinostat),...

FDA Approves Opsynvi (macitentan and tadalafil) for Adults with Pulmonary Arterial Hypertension

RARITAN, NJ, March 22, 2024 – Johnson & Johnson today announced that the U.S. Food and Drug Administration (FDA) has approved Opsynvi® –...

Artificial Intelligence Feasible for Localizing Acute Stroke Lesions

Large language models (LLMs) such as Generative Pretrained Transformers (GPTs) can potentially localize acute stroke lesions, according to a study published...

ACC: Short Sleep Duration Linked to Risk of Developing Hypertension

Short sleep duration is associated with an increased risk of developing hypertension, according to a study scheduled for presentation at the annual meeting...

Supervised Exercise Improves Patient-Reported Outcomes for Metastatic Breast Cancer

Supervised exercise during palliative treatment leads to beneficial effects on fatigue and health-related quality of life (HRQoL) among patients with metastatic...

Timing of Pubertal Development Tied to Adult Cardiometabolic Risk

Pubertal development and its timing may be an important pathway through which early-life exposures shape adulthood cardiometabolic health and disease,...

Obesity Genes Mean Some Folks Must Exercise More for Same Results

Some folks struggling with obesity appear to be hampered by their own genes when it comes to working off those extra pounds, a new study finds. People...

ADHD Meds Tied to Heart Damage in Young Adult Users

ADHD stimulant medications like Ritalin or Adderall appear linked to a heightened risk for cardiomyopathy (a weakening of the heart muscle), and the risk...

Sleep Troubles Can Raise Your Blood Pressure: Study

A major review of data confirms that getting less than the recommended amount of sleep each night is a risk factor for high blood pressure. Data collected...

SCOTUS Appears Skeptical of Arguments to Curb Abortion Pill Access

Following oral arguments presented on Tuesday, the U.S. Supreme Court looked poised to rebuff a legal challenge to women's access to the abortion pill. Mifepristone...

FDA Warns Consumers to Avoid Certain Topical Pain Relief Products Due to Potential for Dangerous Health Effects

The U.S. Food and Drug Administration is warning consumers not to use certain over-the-counter analgesic (pain relief) products that are marketed for topical...

Johnson & Johnson's Nipocalimab Granted U.S. FDA Fast Track Designation to Reduce the Risk of Fetal Neonatal Alloimmune Thrombocytopenia (FNAIT) in Alloimmunized Pregnant Adults

SPRING HOUSE, Pa. March 26, 2024 – Johnson & Johnson announced today that the U.S. Food and Drug Administration (FDA) has granted Fast Track...

Tonix Pharmaceuticals Receives Rare Pediatric Disease Designation from the FDA for TNX-2900 for the Treatment of Prader-Willi Syndrome

Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a biopharmaceutical company with marketed products and a pipeline of development...

Regeneron Provides Update on Biologics License Application for Odronextamab

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S. Food and Drug Administration (FDA) has issued Complete Response Letters (CRLs)...

Can You Build Muscle in Old Age? Yes, and an Expert Has Tips

If you're in your 60s, 70s or even older, you might think your days of productively pumping iron are behind you. That's just not true, said Dr. Adil...

Read more news...

Recently Added

Recently added consumer and prescribing information: Winrevair, Pemgarda, Tryvio, Edurant and Edurant Ped, Tevimbra, Rezdiffra, Tyenne, Wyost, Letybo, Simlandi

For Consumers

For Professionals

For Researchers

Latest FDA New Drug Approvals

  • Winrevair Winrevair (sotatercept) is an activin signaling inhibitor used for the treatment of adults with pulmonary arterial hypertension.
  • Duvyzat Duvyzat (givinostat) is a histone deacetylase inhibitor indicated for the treatment of Duchenne muscular dystrophy in patients 6 years of...
  • Opsynvi Opsynvi (macitentan and tadalafil) is a single tablet combination of the endothelin receptor antagonist (ERA) macitentan and the...

More FDA approvals

Drugs in Development (Not yet approved)

  • Yutrepia Yutrepia (treprostinil) is an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) to...
  • Libervant Libervant (diazepam) is a buccal film formulation of the approved benzodiazepine diazepam in development for the management of seizure clusters.

More drugs in development